Startup Champions Seed Night 2017

Startup Champions Seed Night 2017

Date & Time

Date 26 avril
Time 17:00 - 22:00
Place EPFL
Route Cantonale
Event type Pas de Catégories


(Cet évènement se tiendra en anglais)

The Startup Champions Seed Night, co-organized by EPFL Alumni, the Innogrants and venturelab, is the annual startups presentations & pitch competition bringing together the most promising entrepreneurs from EPFL and the rest of Switzerland. This edition will showcase 23 upcoming startups, including the 20 winners of the venturelab programs and some of the most promising EPFL early stage companies.

Besides the pitch competition where attendees will be voting for the best startup, we are glad to announce a great entrepreneur for the keynote: Tej Tadi, founder and CEO of MindMaze SA. MindMaze is a spin-off of EPFL and was founded in 2011 to develop technologies that help patients recover from brain injuries. It is a breakthrough platform combining virtual reality (VR), computer graphics, brain imaging, neuroscience and rehabilitation. Mindmaze was valued at $1Bio in 2016, which made it a Swiss startup unicorn.

The event will welcome angel investors, mentors, industry leaders, local researchers and students for an audience of 300+ people.

The event is sold out.

The event will be hosted at EPFL Rolex Learning Center Forum

17:00 Doors open for startups exhibition
18:30 Welcome words
19:00 Keynote, Tej Tadi, Founder & CEO MindMaze
19:15 Pitch competition
20:30 Final with the four best startups
20:45 Buffet networking and startups exhibition


The start-ups that will present at the Seed Night 2017:

Represented by Iselin Frøybu.
Alogo Analysis SA is a Swiss incorporated company active in sports analytics. At Alogo, we aim to develop innovative statistics for equestrianism that will increase fans engagement and ultimately educate people on the sport. AlogoSHOW a unique patented system enhance fans experience in venue and raise public interest in the discipline. AlogoMOVE sensors analyze horse’s movement and will allow coaches and riders to precisely quantify their performance and thus improve their training.


Represented by Sandeep Thakur.
ASTROCAST solves the burning need of a low cost global M2M (Machine to Machine) and IoT (Internet of Things) communication service. This is possible through the use of low cost nano-satellites in space and highly optimal communication protocol designed for global mobility applications. No matter whatever and wherever the clients’ assets are, it is now affordable to connect them to Cloud through ASTROCAST network. ASTROCAST service helps clients in remote monitoring, predictive maintenance, intelligent data and geolocation services in a cost-effective manner.

Represented by Hervé Muyal.
BIGVU is the fastest and easiest way to create authentic and captivating videos for social media, news, education, corporate communications and content marketing.

Represented by Rodrigo Araujo Fraga da Silva.
Comphya develops an active implantable medical device to restore the erectile function of patients who are non-responsive to oral drugs (e.g. Viagra or Cialis). To achieve erection, these patients have access to problematic and outdated methods such as intrapenile injections of vasodilators or penile implants. Comphya fills the need for better modalities for these patients, with a main focus on spinal cord injury and prostatectomy patients, both large segments with high potential of use.

Represented by Martijn Bosch.
Darix makes augmented reality applications for professionals. We are successfully supporting firefighters to see through smoke and better understand their environment, technicians to address difficult tasks on-site, and are using the powers of augmented reality to support professionals during their work.

Represented by Patrizia Marschalkova.
Lymphedema is a frequent and serious complication of cancer therapies. It is a chronic and progressive disease, mostly outlined by the swelling of a limb due to improper function of the lymphatic system. After the disease has manifested, conservative treatments help avoid its worsening, but compelte reversal is burdensome. Dicronis helps to drastically improve its prognosis by providing the earliest lymphedema diagnostic, based on a micro-needles technology used to assess the lymphatic function in a simple, safe, minimally-invasive and cost-effective manner.

Represented by Georges Muller.
Each cell of our body is unique. DispenCell is an enabler for personnlized medicine as it will allow researchers to isolate indiviual cells more efficiently only by reducing lab time and validation time.

Represented by Xiaolin (Lin) Briod-Wang.
Flyability is a Swiss company building safe drones for inaccessible places. By allowing drones to be used safely in cities, inside buildings, and in contact with people, it enables new interactions and services with UAVs and solving the two most critical issues of one of the fastest growing industries: collisions and injury risks. The company’s first market is in industrial inspection where it avoids sending people in dangerous and confined spaces for the inspection of Energy, Heavy Industries, Oil & Gas and Maritime assets. It is also working with Search & Rescue and security professionals to assess emergency situations without putting humans at risk. Flyability is the winner of the 1M USD Drones for Good Award 2015 and over 10 other technology and business prizes.

Represented by Andreas Schmocker.
Every day, more than 1 million implants are placed using open surgery. Lumigbo developed a technology to build up implants inside the body using an access channel of less than half a millimeter in diameter. The procedure can be used for almost any type of polymer-based implant.

Represented by Urs Frey.
MaxWell Biosystems develops and distributes the most advanced electrophysiology cell-imaging platform for high-throughput assays to accelerate drug development. The toolset, consisting of an integrated sensor chip, acquisition hardware and software delivers unprecedentedly accurate results. This solution can advance and accelerate drug discovery and basic neurosciences.

Represented by Rafael Hostettler.
Medical Templates developed the “Puncture Cube”, an ingeniously simple approach to computed tomography (CT) guided needle navigation in the body for biopsies and pain therapy. Targeted at interventional radiologists, the technology reduces radiation, intervention time and variance, while increasing patient comfort and safety. The solution has seen extremely positive user feedback. MedicalTemplates is now aiming towards FDA approval by the End of 2017 to enter the US market.

Represented by Laurent Chatelanat.
There are hundreds of tools on the Internet to build websites or e-commerce shops in a few minutes, without any programming knowledge. However, there is nothing yet with the same ease of use to build applications or software. Olympe empowers anyone to translate ideas into software solutions, from “brain to market”, in a few clicks. Combining visual thinking and artificial intelligence, users can build their own tailor made software easily and intuitively.

Represented by Kai Eberhardt.
Oviva is a leading provider of technology-enabled medical nutritional therapy by applying technology to improve patient experience, care efficiency and effectiveness. Oviva disrupts the traditional model by a proprietary technology to provide remote patient treatment via a smartphone app with an expert system support. The business model is to provide services with employed dietitians directly in Switzerland, Germany and the UK, and license the technology to healthcare providers internationally.

Represented by Anthony Aho.
PB&B is a Swiss medtech startup focused on Aesthetics & Anti-aging medicine. PB&B’s platform technology is also under development to render body shaping and reconstructive procedures in plastic surgery both natural & non-surgical.

Represented by Carlos Ciller.
RetinAI Medical is a startup based in Bern, Switzerland, focused on empowering eye care professionals and doctors using artificial intelligence. RetinAI uses the latest machine learning techniques (deep learning) and medical image processing to reach human-level performance for the assisted automatic evaluation of Optical Coherence Tomography (OCT), Fundus Image Photography and retinal Angiography. These techniques can be applied to the early detection and screening of the following pathologies: Age-related Macular Degeneration (AMD), Diabetic Retinopathy (DR), Glaucoma, and a multitude of neurodegenerative diseases such as Alzheimer’s, Parkinson’s, multiple sclerosis (MS), and amyotrophic lateral sclerosis (ALS).

Represented by Ivana Balic.
SonoView develops an accurate, safe and cost-effective imaging technology to help health professionals detect breast cancer at an earlier and more treatable stage. The technology aims at obtaining the same image quality as Magnetic Resonance Scanning at one tenth of its cost.

Represented by Mattias Larsson.
SUINCoL develops tissue regeneration therapies, with the primary focus on non-invasive treatment of stress urinary incontinence. SUINCoL’s main goal is to motivate investors to fund further development of its products and their respective clinical introduction.


Represented by Wiktor Bourée.
Technis revolutionises one major aspect of facility management : activity monitoring. Staying true to its swiss roots, Technis does so in the most discrete and precise way: through the flooring. By making the surface sensitive and by coupling this surface to powerful artificial intelligence, a real-time overview of the activity in your infrastructure is made accessible from any internet-connected device. Your personalised dashboard furthermore allows for external data crossing, thus allowing for resource optimisation, queue management and activity prediction.


Represented by Peter Kaeser.
VIU prescription glasses and sunglasses unite brilliant design with a transparent manufacturing process and fair prices. VIU neither wants to imitate major labels nor follow mass production lines. The sole aim is to create utterly unique and inspirational products. The collections are designed in Switzerland by Fabrice Aeberhard, VIU’s Creative Director. Each individual pair is then crafted in more than 80 manual steps at a traditional manufacturer in the Italian Dolomites and on Honshu Island. By delivering directly from the manufacturer to the customer, VIU offers high-quality design and sustainable products at revolutionary prices.

Represented by Esmeralda Megally.
Xsensio develops next-generation Lab-on-Skin wearable devices that uniquely exploit biochemical information at the surface of our skin, providing unprecedented real-time information about our health and wellness, in a simple, non-invasive way.

Represented by Paolo Romano.
Zaphiro Technologies develops and commercializes a power-grid monitoring and automation system that helps electrical utilities to operate their grids more reliably, efficiently and cost effectively during both normal and emergency conditions. This is possible thanks to synchronised sensors that transmit their data in real-time to a grid controller unit integrating advanced algorithms to protect and control the grid.

Represented by Xiang Li.
ZuriMED commercializes a revolutionary device for surgical knee ligament reconstruction, the “Bone-Tendon-Bone (BTB) Conversion-Kit™”. The solution effectively converts a less painful hamstring autograft (a patient’s own tissue), or any other flexible graft, into a higher performance BTB-like graft.


The event is kindly supported by:


Acces map

Chargement de la carte…